|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Aquestive Therapeutics (NASDAQ: AQST) through any online brokerage.
The latest price target for Aquestive Therapeutics (NASDAQ: AQST) was reported by RBC Capital on September 28, 2020. The analyst firm set a price target for 7.00 expecting AQST to rise to within 12 months (a possible 71.99% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $4.07 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Aquestive Therapeutics.
There is no upcoming split for Aquestive Therapeutics.
Aquestive Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.